Cargando…
That Escalated Quickly: Remdesivir's Place in Therapy for COVID-19
Remdesivir is a nucleoside antiviral recently studied in several randomized trials for treatment of COVID-19. The available observational and prospective data are conflicting, requiring clinicians to critically evaluate and reconcile results to determine patient populations that may optimally benefi...
Autores principales: | Davis, Matthew R., McCreary, Erin K., Pogue, Jason M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Healthcare
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7348566/ https://www.ncbi.nlm.nih.gov/pubmed/32651941 http://dx.doi.org/10.1007/s40121-020-00318-1 |
Ejemplares similares
-
Monoclonals for patients hospitalised with COVID-19
por: Pogue, Jason M, et al.
Publicado: (2022) -
Coronavirus Disease 2019 Treatment: A Review of Early and Emerging Options
por: McCreary, Erin K, et al.
Publicado: (2020) -
The place for remdesivir in COVID-19 treatment
por: Young, Barnaby, et al.
Publicado: (2021) -
Use of remdesivir in children with COVID-19 infection: a quick narrative review
por: La Tessa, Andrea, et al.
Publicado: (2021) -
136. Impact of a Tele-Stewardship and Tele-Infection Prevention Program on Hospital-Onset Clostridioides Difficile Rates in a Community Three-Hospital Health System
por: Davis, Matthew R, et al.
Publicado: (2023)